IRIS

Immune modulation of pathologic complete response after neoadjuvant HER2-directed therapies in the NeoSphere trial / Bianchini, G; Pusztai, L; Pienkowski, T; Im, Yh; Bianchi, Gv; Tseng, Lm; Liu, Mc; Lluch, A; Galeota, E; Magazzù, D; de la Haba-Rodríguez, J; Oh, Dy; Poirier, B; Pedrini, Jl; Semiglazov, V; Valagussa, P; Gianni, L.. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - (2015).

Immune modulation of pathologic complete response after neoadjuvant HER2-directed therapies in the NeoSphere trial.

Bianchini G;
2015-01-01
2015
2-s2.0-84949965164
WOS:000366374700009
Immune modulation of pathologic complete response after neoadjuvant HER2-directed therapies in the NeoSphere trial / Bianchini, G; Pusztai, L; Pienkowski, T; Im, Yh; Bianchi, Gv; Tseng, Lm; Liu, Mc; Lluch, A; Galeota, E; Magazzù, D; de la Haba-Rodríguez, J; Oh, Dy; Poirier, B; Pedrini, Jl; Semiglazov, V; Valagussa, P; Gianni, L.. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - (2015).
none
17
info:eu-repo/semantics/article
262
Bianchini, G; Pusztai, L; Pienkowski, T; Im, Yh; Bianchi, Gv; Tseng, Lm; Liu, Mc; Lluch, A; Galeota, E; Magazzù, D; de la Haba-Rodríguez, J; Oh, Dy; P...espandi
1 Contributo su Rivista::1.1 Articolo in rivista
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/153898
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 126
  • ???jsp.display-item.citation.isi??? 117
social impact